| Literature DB >> 30602519 |
Amit N Pandya1, Pavan K Prathipati2, Pooja Hegde1, Wei Li2, Kyle F Graham1, Subhra Mandal2, Kristen M Drescher3, Christopher J Destache2, Diane Ordway4, Mary Jackson4, E Jeffrey North5.
Abstract
Nontuberculous mycobacteria (NTM) pathogens particularly infect patients with structural lung disorders. We previously reported novel indole-2-carboxamides (ICs) that are active against a wide panel of NTM pathogens. This study discloses in vivo data for two lead molecules (compounds 5 and 25) that were advanced for efficacy studies in Mycobacterium abscessus-infected mouse models. Oral administration of the lead molecules showed a statistically significant reduction in the bacterial loads in lung and spleen of M. abscessus-infected mice.Entities:
Keywords: MmpL3; Mycobacterium; Mycobacterium abscessus; NTM; indole-2-carboxamide; nontuberculous mycobacteria
Mesh:
Substances:
Year: 2019 PMID: 30602519 PMCID: PMC6395937 DOI: 10.1128/AAC.02245-18
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191